• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by MaxLinear Inc.

    6/6/24 4:32:37 PM ET
    $MXL
    Semiconductors
    Technology
    Get the next $MXL alert in real time by email
    S-8 1 a20240606forms-8.htm S-8 Document

    As filed with the Securities and Exchange Commission on June 6, 2024
    Registration No. 333-          .  
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM S-8
    REGISTRATION STATEMENT
    UNDER THE SECURITIES ACT OF 1933
    MaxLinear, Inc.
    (Exact name of registrant as specified in its charter)
    Delaware14-1896129
    (State or other jurisdiction of
    incorporation or organization)
    (I.R.S. Employer
    Identification No.)
    5966 La Place Court, Suite 100
    Carlsbad, California 92008
    (Address of Principal Executive Offices)(Zip Code)
    2024 Inducement Equity Incentive Plan
    (Full title of the plan)
    Kishore Seendripu, Ph.D.
    5966 La Place Court, Suite 100
    Carlsbad, California 92008
    (Name and address of agent for service)
    (760) 692-0711
    (Telephone number, including area code, of agent for service)
    Copies to:
    Mark Baudler
    Wilson Sonsini Goodrich & Rosati
    Professional Corporation
    650 Page Mill Road
    Palo Alto, California 94304
    (650) 493-9300
    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
    Large accelerated filer☑Accelerated filer☐
    Non-accelerated filer☐Smaller reporting company☐
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act ☐
        



    EXPLANATORY NOTE

    This Registration Statement on Form S-8 (the “Registration Statement”) is filed by MaxLinear, Inc. (the “Registrant”) for the purpose of registering 4,000,000 shares of common stock of the Registrant reserved for issuance under the MaxLinear, Inc. 2024 Inducement Equity Incentive Plan.


    PART I
    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
    The information specified in Item 1 and Item 2 of Part I of Form S-8 is omitted from this Registration Statement on Form S-8 in accordance with the provisions of Rule 428 under the Securities Act of 1933, as amended (the “Securities Act”), and the introductory note to Part I of Form S-8. The documents containing the information specified in Part I of Form S-8 will be delivered to the participants in the equity benefit plans covered by this Registration Statement as specified by Rule 428(b)(1) under the Securities Act. These documents and the documents incorporated by reference in this Registration Statement pursuant to Item 3 of Part II of Form S-8, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.

    PART II
    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
    Item 3. Incorporation of Documents by Reference.
    The Registrant hereby incorporates by reference into this Registration Statement the following documents previously filed with the Securities and Exchange Commission (the “Commission”):
    (1)The Registrant’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the Commission on January 31, 2024;
    (2)The information incorporated by reference into the Registrant’s Annual Report on Form 10-K for the year ended December 31, 2023 from its Definitive Proxy Statement on Schedule 14A, filed with the Commission on April 4, 2024;
    (3)The Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024, filed with the Commission on April 24, 2024;
    (4)The Registrant’s Current Reports on Form 8-K, filed with the Commission on January 8, 2024, May 24, 2024 and May 29, 2024;
    (5)All other reports filed with the Commission pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (other than the reports, or portions thereof, deemed to have been furnished and not filed with the Commission) since the end of the fiscal year covered by the Annual Report referred to in (1) above; and
    (6)The description of the Registrant’s common stock contained in the Registrant’s Registration Statement on Form 8-A, filed with the Commission on December 10, 2021, including any amendment or report filed for the purpose of updating such description.
    All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.



    Item 4. Description of Securities.
    Not applicable.
    Item 5. Interests of Named Experts and Counsel.
    Not applicable.
    Item 6. Indemnification of Directors and Officers.
    Section 145 of the Delaware General Corporation Law generally empowers a corporation to indemnify its directors and officers against expenses incurred in connection with an action, suit or proceeding related to such person's service to the corporation, provided that the person acted in good faith and in a manner the person reasonably believed to be in or not opposed to the best interests of the corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to believe the person’s conduct was unlawful, and to purchase insurance with respect to liability arising out of their capacity or status as directors and officers. The Delaware General Corporation Law further provides that the indemnification permitted thereunder shall not be deemed exclusive of any other rights to which the directors and officers may be entitled under the corporation’s bylaws, any agreement, a vote of stockholders or disinterested directors or otherwise. The amended and restated certificate of incorporation of the Registrant provides for the indemnification of the Registrant’s directors and officers to the fullest extent permitted under the Delaware General Corporation Law.
    In addition, the amended and restated bylaws of the Registrant require, subject to certain limitations, the Registrant to fully indemnify any person who was or is made a party or is threatened to be made a party to or is otherwise involved in any action, suit or proceeding (whether civil, criminal, administrative or investigative) by reason of the fact that such person is or was a director or officer of the Registrant, or is or was a director or officer of the Registrant and was serving at the Registrant’s request as a director, officer or trustee of another corporation or of a partnership, joint venture, trust or other enterprise (including service with respect to an employee benefit plan), against all expense, liability and loss (including attorneys’ fees, judgments, fines, Employee Retirement Income Security Act of 1974 (ERISA) excise taxes or penalties and amounts paid in settlement) reasonably incurred or suffered by such person in connection with such action, suit or proceeding, to the fullest extent permitted by the Delaware General Corporation Law.

    Section 102(b)(7) of the Delaware General Corporation Law permits a corporation to provide in its certificate of incorporation that a director or an officer of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director or officer, provided that such provision may not eliminate or limit the liability of (1) a director or officer for any breach of the director’s or officer’s duty of loyalty to the corporation or its stockholders, (2) a director or officer for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (3) a director for payments of unlawful dividends or unlawful stock repurchases or redemptions, (4) a director or officer for any transaction from which the director or officer derived an improper personal benefit, or (5) an officer in any action by or in the right of the corporation. The officers who may be exculpated pursuant to Section 102(b)(7) of the Delaware General Corporation Law are only officers who at the time of an act or omission as to which liability is asserted are deemed to have consented to service of process to the registered agent of the corporation under Delaware law. The Registrant’s amended and restated certificate of incorporation, as amended, provides that the Registrant’s directors and officers shall not be personally liable to it or its stockholders for monetary damages for breach of fiduciary duty as a director or officer to the fullest extent permitted by the Delaware General Corporation Law and that if the Delaware General Corporation Law is amended to authorize corporate action further eliminating or limiting the personal liability of directors or officers, then the liability of the Registrant’s directors and officers shall be eliminated or limited to the fullest extent permitted by the Delaware General Corporation Law, as so amended.
    Section 174 of the Delaware General Corporation Law generally provides, among other things, that a director under whose administration a willful or negligent violation of the restrictions on unlawful payments of dividends or unlawful stock repurchases or redemptions occurs may be held liable to the full amount of the dividend unlawfully paid, or to the full amount unlawfully paid for the repurchase or redemption of the corporation’s stock, with interest from the time such liability accrued. A director who was either absent when the unlawful actions were taken, or dissented at the time, may avoid liability by causing his or her dissent to be entered in the books containing minutes of the proceedings of the board of directors at the time such action occurred or immediately after such absent director receives notice of the unlawful acts.
    As permitted by the Delaware General Corporation Law, the Registrant has entered into separate indemnification agreements with each of the Registrant’s directors and executive officers which would require the Registrant, among other things, to indemnify them against certain liabilities which may arise by reason of their status as directors or executive officers.



    The Registrant has obtained insurance policies under which its directors and officers are insured, within the limits and subject to the limitations of those policies, against certain expenses in connection with the defense of, and certain liabilities which might be imposed as a result of, actions, suits or proceedings to which they are parties by reason of being or having been directors or officers. The coverage provided by these policies may apply whether or not the Registrant would have the power to indemnify such person against such liability under the provisions of the Delaware General Corporation Law.
    These indemnification provisions and the indemnification agreements entered into between the Registrant and the Registrant’s officers and directors may be sufficiently broad to permit indemnification of the Registrant’s officers and directors for liabilities (including reimbursement of expenses incurred) arising under the Securities Act of 1933, as amended.
    Item 7. Exemption from Registration Claimed.
    Not applicable.



    PART II
    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    Item 8. Exhibits.
    Exhibit
    Number
    Description
    4.1
    Specimen Common Stock Certificate of the Registrant (incorporated herein by reference to Exhibit 4.1 to the Registrant’s Amendment No. 1 to Form 8-A (File No. 001-34666), filed on March 30, 2017).
    4.2+
    2024 Inducement Equity Incentive Plan and related form agreements (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Form 8-K (File No. 001-34666), filed on May 29, 2024).
    5.1
    Opinion of Wilson Sonsini Goodrich & Rosati, Professional Corporation.
    23.1
    Consent of Independent Registered Public Accounting Firm.
    23.2
    Consent of Wilson Sonsini Goodrich & Rosati, Professional Corporation (contained in Exhibit 5.1 hereto).
    24.1
    Power of Attorney (contained on signature page hereto).
    107.1
    Filing Fee Table
    +Indicates management contract or compensatory plan, contract or arrangement.


        


    Item 9. Undertakings.

    (a) The undersigned Registrant hereby undertakes:

    (1) to file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

    (i) to include any prospectus required by Section 10(a)(3) of the Securities Act;

    (ii) to reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement; and

    (iii) to include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement;

    provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the registration statement.

    (2) that, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

    (3) to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

    (b) The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by



    reference in the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

    (c) Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.



    SIGNATURES
    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Carlsbad, State of California, on this 6th day of June 2024.
    MAXLINEAR, INC.
    (Registrant)
    By:/s/ KISHORE SEENDRIPU, PH.D.
    Kishore Seendripu, Ph.D.
    President and Chief Executive Officer
    Date: June 6, 2024(Principal Executive Officer)



    POWER OF ATTORNEY
    KNOW ALL PERSONS BY THESE PRESENTS, that each individual whose signature appears below constitutes and appoints Kishore Seendripu, Ph.D. and Steven G. Litchfield, and each of them, his or her true and lawful attorneys-in-fact and agents with full power of substitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement and to file the same, with all exhibits thereto and all documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or his or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
    Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated:
    SignatureTitleDate
    /s/ KISHORE SEENDRIPU, PH.D.President and Chief Executive OfficerJune 6, 2024
    Kishore Seendripu, Ph.D.(Principal Executive Officer)
    /s/ STEVEN G. LITCHFIELDChief Financial Officer and Chief Corporate Strategy OfficerJune 6, 2024
    Steven G. Litchfield(Principal Financial Officer)
    /s/ CONNIE KWONGCorporate ControllerJune 6, 2024
    Connie Kwong(Principal Accounting Officer)
    /s/ THOMAS E. PARDUNLead DirectorJune 6, 2024
    Thomas E. Pardun
    /s/ DANIEL A. ARTUSIDirectorJune 6, 2024
    Daniel A. Artusi
    /s/ CAROLYN D. BEAVERDirectorJune 6, 2024
    Carolyn D. Beaver
    /s/ GREGORY P. DOUGHERTYDirectorJune 6, 2024
    Gregory P. Dougherty
    /s/ TSU-JAE KING LIU, PH.D.DirectorJune 6, 2024
    Tsu-Jae King Liu, Ph.D.
    /s/ ALBERT J. MOYERDirectorJune 6, 2024
    Albert J. Moyer
    /s/ THEODORE TEWKSBURY, PH.D.DirectorJune 6, 2024
    Theodore Tewksbury, Ph.D.


    Get the next $MXL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MXL

    DatePrice TargetRatingAnalyst
    11/22/2024$14.00Equal Weight
    Wells Fargo
    10/1/2024$15.00Positive → Neutral
    Susquehanna
    7/25/2024Buy → Hold
    Needham
    7/17/2024$20.00 → $38.00Hold → Buy
    Craig Hallum
    4/4/2024$30.00Market Perform → Outperform
    Northland Capital
    2/1/2024$28.00 → $25.00Buy
    Needham
    1/3/2024$35.00 → $25.00Overweight → Equal Weight
    Wells Fargo
    10/26/2023$35.00 → $18.00Buy → Neutral
    ROTH MKM
    More analyst ratings

    $MXL
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wells Fargo initiated coverage on MaxLinear with a new price target

    Wells Fargo initiated coverage of MaxLinear with a rating of Equal Weight and set a new price target of $14.00

    11/22/24 7:50:25 AM ET
    $MXL
    Semiconductors
    Technology

    MaxLinear downgraded by Susquehanna with a new price target

    Susquehanna downgraded MaxLinear from Positive to Neutral and set a new price target of $15.00

    10/1/24 8:14:55 AM ET
    $MXL
    Semiconductors
    Technology

    MaxLinear downgraded by Needham

    Needham downgraded MaxLinear from Buy to Hold

    7/25/24 7:22:01 AM ET
    $MXL
    Semiconductors
    Technology

    $MXL
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MaxLinear, Inc. Announces First Quarter 2026 Financial Conference Participation

    MaxLinear, Inc. (NASDAQ:MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, today announced that it will participate in the following financial conferences in the first quarter 2026: 28th Annual Needham Growth Conference in New York on Jan. 13th. MaxLinear's presentation is scheduled for 8:45 a.m. ET. A webcast of the session will be available at https://investors.maxlinear.com. Susquehanna 15th Annual Technology Conference in New York on Feb. 26th Loop Capital Markets 7th Annual Investor Conference (virtual) on March 9th Stifel 2026 Technology One-on-One Conference in New York on March 10th About MaxLinear, Inc. MaxLinear

    1/8/26 4:35:00 PM ET
    $MXL
    Semiconductors
    Technology

    MaxLinear, Inc. Announces Conference Call to Review Fourth Quarter 2025 Financial Results

    Thursday, Jan. 29, 2026 at 1:30 p.m. Pacific Time; 4:30 p.m. Eastern Time MaxLinear, Inc. (NASDAQ:MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, announced today that it will release its financial results for the fourth quarter 2025 after the close of market on Thursday, Jan. 29, 2026. The company will host a corresponding conference call at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time. Conference Call Details Date: Jan. 29, 2026 Time: 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time Hosts: Kishore Seendripu, Ph.D., Chief Executive Officer and Steve Litchfield, Chief Financial Officer a

    1/7/26 4:35:00 PM ET
    $MXL
    Semiconductors
    Technology

    MaxLinear Announces New Employee Inducement Grants

    MaxLinear, Inc. (NASDAQ:MXL)("MaxLinear"), a leading provider of RF, analog, digital and mixed-signal integrated circuits, today announced that it has granted equity awards ("the Inducement Grants") under its 2024 Inducement Equity Incentive Plan to newly hired employees. The Inducement Grants were previously approved by the Compensation Committee of the Board of Directors of MaxLinear. Information regarding the equity awards can be found on MaxLinear's investor relations website at: https://investors.maxlinear.com/ About MaxLinear, Inc. MaxLinear, Inc. (NASDAQ:MXL) is a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits for access and conne

    11/21/25 4:35:00 PM ET
    $MXL
    Semiconductors
    Technology

    $MXL
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman, President and CEO Seendripu Kishore bought $1,401,592 worth of shares (108,303 units at $12.94) (SEC Form 4)

    4 - MAXLINEAR, INC (0001288469) (Issuer)

    7/30/24 7:55:22 PM ET
    $MXL
    Semiconductors
    Technology

    $MXL
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by MaxLinear Inc.

    SCHEDULE 13G - MAXLINEAR, INC (0001288469) (Subject)

    2/5/26 1:31:51 PM ET
    $MXL
    Semiconductors
    Technology

    Amendment: SEC Form SCHEDULE 13G/A filed by MaxLinear Inc.

    SCHEDULE 13G/A - MAXLINEAR, INC (0001288469) (Subject)

    1/30/26 2:20:07 PM ET
    $MXL
    Semiconductors
    Technology

    SEC Form S-8 filed by MaxLinear Inc.

    S-8 - MAXLINEAR, INC (0001288469) (Filer)

    1/29/26 4:11:47 PM ET
    $MXL
    Semiconductors
    Technology

    $MXL
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Artusi Daniel A sold $463,051 worth of shares (29,802 units at $15.54), decreasing direct ownership by 71% to 12,141 units (SEC Form 4)

    4 - MAXLINEAR, INC (0001288469) (Issuer)

    10/30/25 5:14:35 PM ET
    $MXL
    Semiconductors
    Technology

    Amendment: SEC Form 4 filed by Director Dougherty Greg

    4/A - MAXLINEAR, INC (0001288469) (Issuer)

    10/10/25 6:44:43 PM ET
    $MXL
    Semiconductors
    Technology

    Amendment: SEC Form 4 filed by Director Moyer Albert J

    4/A - MAXLINEAR, INC (0001288469) (Issuer)

    10/10/25 6:44:38 PM ET
    $MXL
    Semiconductors
    Technology

    $MXL
    Leadership Updates

    Live Leadership Updates

    View All

    Daniel Artusi Joins Gallium Semiconductor Advisory Board

    Gallium Semiconductor, an innovative supplier of RF Gallium Nitride (GaN) semiconductor solutions for 5G mobile communications, today announced the appointment of industry veteran Daniel Artusi to its Advisory Board. With forty years of experience leading global semiconductor companies, Mr. Artusi will play an instrumental role in furthering Gallium Semi's strategic goals, expanding its customer relationships and capturing its market expansion opportunities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220222005224/en/Daniel Artusi Joins Gallium Semiconductor Advisory Board (Photo: Business Wire) "We are extremely honored to we

    2/22/22 9:00:00 AM ET
    $MINM
    $MXL
    Telecommunications Equipment
    Utilities
    Semiconductors
    Technology

    MaxLinear Appoints Tsu-Jae King Liu to Its Board of Directors

    CARLSBAD, Calif.--(BUSINESS WIRE)--MaxLinear, Inc. (NYSE: MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, announced today the appointment of Dr. Tsu-Jae King Liu, Dean and Professor of the College of Engineering at the University of California, Berkeley, to its board of directors. Dr. Liu has been appointed a Class I director with a term continuing until the 2022 annual meeting of stockholders, effective immediately. “We are extremely pleased to welcome Dr. Liu to our board of directors,” said Kishore Seendripu, Ph.D., MaxLinear’s Chairman and Chief Executive Officer. “Her world renowned expertise in semiconductor process te

    3/31/21 8:35:00 AM ET
    $MXL
    Semiconductors
    Technology

    Zoom Telephonics Completes Merger and Rebrands as Minim (OTCQB: MINM); Company Announces Reconstituted Board of Directors

    Combination Brings Intelligent WiFi and Cable Modem Products Operated Under an Exclusive Motorola® Brand License to the Multi-Billion Dollar Consumer and Business Connectivity Solutions Market MANCHESTER, NH, Dec. 07, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire – Zoom Telephonics, Inc. (“Zoom”) (OTCQB: ZMTP), a leading creator of cable modems and other Internet access products under the Motorola brand, today announced that it has completed its merger with Minim Inc., the AI-driven WiFi management and IoT security platform for homes, SMBs, and broadband service providers. Beginning December 8, 2020, the combined company will begin trading as “MINM” (OTCQB: MINM). “Secure, robust home co

    12/7/20 8:45:00 AM ET
    $MXL
    Semiconductors
    Technology

    $MXL
    Financials

    Live finance-specific insights

    View All

    MaxLinear, Inc. Announces Conference Call to Review Fourth Quarter 2025 Financial Results

    Thursday, Jan. 29, 2026 at 1:30 p.m. Pacific Time; 4:30 p.m. Eastern Time MaxLinear, Inc. (NASDAQ:MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, announced today that it will release its financial results for the fourth quarter 2025 after the close of market on Thursday, Jan. 29, 2026. The company will host a corresponding conference call at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time. Conference Call Details Date: Jan. 29, 2026 Time: 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time Hosts: Kishore Seendripu, Ph.D., Chief Executive Officer and Steve Litchfield, Chief Financial Officer a

    1/7/26 4:35:00 PM ET
    $MXL
    Semiconductors
    Technology

    MaxLinear, Inc. Announces Conference Call to Review Third Quarter 2025 Financial Results

    Thursday, Oct. 23, 2025 at 1:30 p.m. Pacific Time; 4:30 p.m. Eastern Time MaxLinear, Inc. (NASDAQ:MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, announced today that it will release its financial results for the third quarter 2025 after the close of market on Thursday, Oct. 23, 2025. The company will host a corresponding conference call at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time. Conference Call Details Date: Oct. 23, 2025 Time: 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time Hosts: Kishore Seendripu, Ph.D., Chief Executive Officer and Steve Litchfield, Chief Financial Officer and C

    10/1/25 4:35:00 PM ET
    $MXL
    Semiconductors
    Technology

    MaxLinear, Inc. Announces Conference Call to Review Second Quarter 2025 Financial Results

    Wednesday, July 23, 2025 at 1:30 p.m. Pacific Time; 4:30 p.m. Eastern Time MaxLinear, Inc. (NASDAQ:MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, announced today that it will release its financial results for the second quarter 2025 after the close of market on Wednesday, July 23, 2025. The company will host a corresponding conference call at 1:30 p.m. Pacific Time, 4:30 p.m. Eastern Time. Conference Call Details Date: July 23, 2025 Time: 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time Hosts: Kishore Seendripu, Ph.D., Chief Executive Officer and Steve Litchfield, Chief Financial Officer

    7/1/25 4:05:00 PM ET
    $MXL
    Semiconductors
    Technology

    $MXL
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by MaxLinear Inc.

    SC 13G/A - MAXLINEAR, INC (0001288469) (Subject)

    11/6/24 9:46:12 AM ET
    $MXL
    Semiconductors
    Technology

    Amendment: SEC Form SC 13G/A filed by MaxLinear Inc.

    SC 13G/A - MAXLINEAR, INC (0001288469) (Subject)

    10/18/24 9:16:25 AM ET
    $MXL
    Semiconductors
    Technology

    SEC Form SC 13G/A filed by MaxLinear Inc. (Amendment)

    SC 13G/A - MAXLINEAR, INC (0001288469) (Subject)

    2/14/24 4:54:53 PM ET
    $MXL
    Semiconductors
    Technology